In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to HFA Silver & Gold Members, Fellows of the ESC and Young combined Members

Impact of short-time physical training on exercise tolerance, renal and hematological parameters in elderly patients with chronic heart failure

Session Poster session 2 Sunday 08:30 - 18:00

Speaker Dragan Marinkovic

Event : Heart Failure 2015

  • Topic : preventive cardiology
  • Sub-topic : Exercise Testing
  • Session type : Poster Session

Authors : D Marinkovic (Nis,RS), M Deljanin-Ilic (Nis,RS), S Ilic (Nis,RS), G Kocic (Nis,RS), B Ilic (Nis,RS), D Petrovic (Nis,RS)

D Marinkovic1 , M Deljanin-Ilic2 , S Ilic2 , G Kocic3 , B Ilic1 , D Petrovic1 , 1Institute for Treatment and Rehabilitation Niska Banja - Nis - Serbia , 2University of Nis, Medical Faculty, Institute of Cardiology Niska Banja - Nis - Serbia , 3University of Nis, Medical faculty, Institute of biochemestry, - Nis - Serbia ,

European Journal of Heart Failure Abstracts Supplement ( 2015 ) 17 ( Supplement 1 ), 224

Back ground: The positive effects of physical training in patients with chronic heart failure (CHF) are reflected in improving exercise tolerance, reduce symptoms and less hospitalization, increasing survival and improving quality of life. Elderly patients have more advanced CHF than younger because they tend to be more sedentary and thus do not note symptoms or do not receive a diagnosis of CHF until their cardiac limitation is advanced. In elderly patients with heart failure are often present anemia and chronic renal failure, which further affect the tolerance of physical exertion.

Objective: To evaluate the effects of short-term physical training on exercise tolerance and value of renal and hematological parameters in elderly patients with CHF.

Patients and Methods: The study involved 78 patients (52 males), with coronary artery disease, mean EF 34.05 ± 3.24%, NYHA II and III, without anemia and/or chronic kidney disease. All patients were included in three-week rehabilitation program at the residential center, with individually prescribed physical training. Before and after rehabilitation, all patients underwent exercise stress test, and from the veins blood samples renal and hematological parameters were measured. In relation to age, patients were divided into three groups: A (<60 yrs: n = 29), B (60-69 yrs; n = 36) and C (≥70 yrs;n = 13).

Results: After rehabilitation, only in group C significantly lower serum creatinine (p = 0.028) was registered, compared to the value before rehabilitation. In groups A and B, there was a decreasing trend of creatinine, but without significance. Serum urea and uric acid in all groups after rehabilitation, showed no significant change. It was also shown that after rehabilitation, only in group B there was a significant reduction in the number of leukocytes (p = 0.037). Other hematologic parameters did not show significant changes. Exercise tolerance improved in all groups (p < 0.001 for all). After the rehabilitation in group C, heart rate at rest, was substantially lower than in the group A and B (p = 0.003).

Conclusion: Residential short-term physical training led to reduction of serum creatinine in the oldest patients (≥70yrs) with heart failure. Reduction of leukocytes is more pronounced in patients aged 60-69. The largest reduction in heart rate at rest was achieved in patients older than 70 years.

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are